Moderna, Inc. vs Teucrium Soybean Fund — how do they compare? Moderna, Inc. trades at $59.72 (market cap $23.60B), while Teucrium Soybean Fund trades at $25.86. The key difference: Teucrium Soybean Fund is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | SOYB | |
|---|---|---|
Market Cap | $23.60B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $81.80 | $25.88 |
52-Week Low | $22.36 | $21.07 |
Enterprise Value | $19.70B | — |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →